Wijeratne T, Grisold W, Dodick D, Carroll W, World Brain (2019) Day 2019: migraine, the painful truth. Lancet Neurol 18:914. https://doi.org/10.1016/s1474-4422(19)30281-9
Wijeratne T, Tang HM, Crewther D, Crewther S (2019) Prevalence of Migraine in the Elderly: a narrated review. Neuroepidemiology 52:104–110. https://doi.org/10.1159/000494758
Wijeratne T, Wijeratne C, Korajkic N, Bird S, Sales C, Riederer F (2023) Secondary headaches - red and green flags and their significance for diagnostics. eNeurologicalSci 32:100473. https://doi.org/10.1016/j.ensci.2023.100473
Article PubMed PubMed Central Google Scholar
Steiner TJ, Stovner LJ, Jensen R, Uluduz D, Katsarava Z (2020) On behalf of lifting the Burden: the global campaign against, H. Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019. J Headache Pain 21:137. https://doi.org/10.1186/s10194-020-01208-0
Article CAS PubMed PubMed Central Google Scholar
Launer LJ, Terwindt GM, Ferrari MD (1999) The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology 53:537–542. https://doi.org/10.1212/wnl.53.3.537
Article CAS PubMed Google Scholar
Ferrari MD, Migraine (1998) Lancet 351:1043–1051. https://doi.org/10.1016/S0140-6736(97)11370-8
Article CAS PubMed Google Scholar
Edvinsson L, Haanes KA, Warfvinge K (2019) Does inflammation have a role in migraine? Nat Rev Neurol 15:483–490. https://doi.org/10.1038/s41582-019-0216-y
Zhang S, Azubuine J, Schmeer C (2023) A systematic literature review on the role of glial cells in the pathomechanisms of migraine. Front Mol Neurosci 16:1219574. https://doi.org/10.3389/fnmol.2023.1219574
Article CAS PubMed PubMed Central Google Scholar
Al-Hayani M, AboTaleb H, Bazi A, Alghamdi B (2023) Depression, anxiety and stress in Saudi migraine patients using DASS-21: local population-based cross-sectional survey. Int J Neurosci 133(3):248–256 Epub 2021 Apr 14. PMID: 33843418
Minen MT, Begasse De Dhaem O, Van Kroon A, Powers S, Schwedt TJ, Lipton R, Silbersweig D (2016) Migraine and its psychiatric comorbidities. J Neurol Neurosurg Psychiatry. 87(7):741-9. https://doi.org/10.1136/jnnp-2015-312233. Epub 2016 Jan 5. PMID: 26733600
Dodick DW (2018) A phase-by-phase review of Migraine Pathophysiology. Headache 58(Suppl 1):4–16. https://doi.org/10.1111/head.13300
Headache Classification Committee of the International Headache Society (IHS) (2018) The International classification of Headache disorders, 3rd edition. Cephalalgia 38(1–211). https://doi.org/10.1177/0333102417738202
Buse DC, Fanning KM, Reed ML, Murray S, Dumas PK, Adams AM, Lipton RB (2019) Life with Migraine: effects on relationships, Career, and Finances from the chronic migraine epidemiology and outcomes (CaMEO) study. Headache: J Head Face Pain 59:1286–1299. https://doi.org/10.1111/head.13613
Aylin Yucel P, Andrew Thach P, Sharanya Kumar P, Catherine Loden BS, Mark Bensink P, Neil Goldfarb BA, Robert Cowan MD (2020) Estimating the Economic Burden of Migraine on US Employers. The American Journal of Managed Care 26
Karaaslan Z, Özçelik P, Ulukan Ç, Ulusoy C, Orhan KS, Orhan EK, Küçükali C, Tüzün E, Baykan B, Akdal G (2020) Plasma levels of inflammatory mediators in vestibular migraine. Int J Neurosci 130:330–335. https://doi.org/10.1080/00207454.2019.1681994
Article CAS PubMed Google Scholar
Yazar HO, Yazar T, Aygün A, Kaygisiz Ş, Kirbaş D (2020) Evaluation of simple inflammatory blood parameters in patients with migraine. Ir J Med Sci 189:677–683. https://doi.org/10.1007/s11845-019-02136-y
Article CAS PubMed Google Scholar
Kursun O, Yemisci M, van den Maagdenberg AMJM, Karatas H (2021) Migraine and neuroinflammation: the inflammasome perspective. J Headache Pain 22:55. https://doi.org/10.1186/s10194-021-01271-1
Article PubMed PubMed Central Google Scholar
Moisset X, Giraud P, Dallel R (2021) Migraine in multiple sclerosis and other chronic inflammatory diseases. Rev Neurol (Paris) 177:816–820. https://doi.org/10.1016/j.neurol.2021.07.005
Article CAS PubMed Google Scholar
Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, Zhang X, Wang WM, Qiu SJ, Zhou J et al (2014) Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res 20:6212–6222. https://doi.org/10.1158/1078-0432.Ccr-14-0442
Article CAS PubMed Google Scholar
Wijeratne T, Crewther S, Post (2020) -COVID 19 neurological syndrome (PCNS); a novel syndrome with challenges for the global neurology community. J Neurol Sci 419:117179. https://doi.org/10.1016/j.jns.2020.117179
Article CAS PubMed PubMed Central Google Scholar
Wijeratne T, Wijeratne C (2021) Clinical utility of serial systemic immune inflammation indices (SSIIi) in the context of post covid-19 neurological syndrome (PCNS). J Neurol Sci 423:117356. https://doi.org/10.1016/j.jns.2021.117356
Article CAS PubMed PubMed Central Google Scholar
Bonura A, Alesina A, Sapio E, Brunelli N, Marcosano M, Altamura C, Vernieri F (2024) Acute medications’ intake for migraine: a one-year report in patients undergoing first evaluation at a third level Italian headache center. Front Neurol 15:1450039. https://doi.org/10.3389/fneur.2024.1450039
Article PubMed PubMed Central Google Scholar
Patil S, Nadaf N, Gupta S, Barai P, Makhija S, Lodha P, Patel C, Gondane AA, Pawar D, Sharma A (2024) A comparative analysis of the efficacy and safety of Nimesulide/Paracetamol fixed-dose combination with other NSAIDs in Acute Pain Management: a randomized, prospective, Multicenter, active-controlled study (the SAFE-2 study). Cureus 16:e58859. https://doi.org/10.7759/cureus.58859
Article PubMed PubMed Central Google Scholar
Wei HL, Yu YS, Wang MY, Zhou GP, Li J, Zhang H, Zhou Z (2024) Exploring potential neuroimaging biomarkers for the response to non-steroidal anti-inflammatory drugs in episodic migraine. J Headache Pain 25:104. https://doi.org/10.1186/s10194-024-01812-4
Article CAS PubMed PubMed Central Google Scholar
Hird MA, Sandoe CH (2024) Migraine Management in medically complex patients: a Narrative Review. Curr Neurol Neurosci Rep 24:423–438. https://doi.org/10.1007/s11910-024-01361-y
Kim KY, Ko HY, Bea S, Lee HJ, Shin JY, Chu MK (2024) Treatment patterns and persistence among patients newly diagnosed with migraine in South Korea: a Retrospective Analysis of Health Claims Data. J Clin Neurol 20:529–536. https://doi.org/10.3988/jcn.2023.0485
Article PubMed PubMed Central Google Scholar
Arca KN, Smith JH, Chiang CC, Starling AJ, Robertson CE, Halker Singh RB, Schwedt TJ, Kissoon NR, Garza I, Rozen TD et al (2020) COVID-19 and Headache Medicine: a narrative review of non-steroidal anti-inflammatory drug (NSAID) and corticosteroid use. Headache 60:1558–1568. https://doi.org/10.1111/head.13903
Article PubMed PubMed Central Google Scholar
Silva AVD, Kiy LMC, Alves CA, Kirylko GC, Bello VA, Poli-Frederico RC (2021) Impact of headache on a supplemental healthcare emergency unit and on use of opioids. Arq Neuropsiquiatr 79:579–583. https://doi.org/10.1590/0004-282x-anp-2020-0188
Yang S, Orlova Y, Lipe A, Boren M, Hincapie-Castillo JM, Park H, Chang CY, Wilson DL, Adkins L, Lo-Ciganic WH (2022) Trends in the management of Headache disorders in US Emergency departments: analysis of 2007–2018 National Hospital Ambulatory Medical Care Survey Data. J Clin Med 11. https://doi.org/10.3390/jcm11051401
Aczél T, Körtési T, Kun J, Urbán P, Bauer W, Herczeg R, Farkas R, Kovács K, Vásárhelyi B, Karvaly GB et al (2021) Identification of disease- and headache-specific mediators and pathways in migraine using blood transcriptomic and metabolomic analysis. J Headache Pain 22:117. https://doi.org/10.1186/s10194-021-01285-9
Article CAS PubMed PubMed Central Google Scholar
Forcelini CM, Dantas DC, Luz C, Santin R, Stein AT, Barros HM, Barea LM (2011) Analysis of leukocytes in medication-overuse headache, chronic migraine, and episodic migraine. Headache 51:1228–1238. https://doi.org/10.1111/j.1526-4610.2011.01902.x
留言 (0)